[Form 4] Strategy Inc Insider Trading Activity
Rhea-AI Filing Summary
An executive at Strategy Inc (MSTR) exercised options and sold shares on 10/07/2025. The reporting person exercised an employee stock option to acquire 30,000 Class A shares at an exercise price of $40.46 and immediately sold 30,000 Class A shares in multiple transactions at weighted-average prices between $355.48 and $359.20 (reported weighted averages: $356.051, $357.139, $358.045, $358.82). After these transactions the reporting person’s direct Class A ownership falls to 12,726 shares. The report also lists ownership of several series of preferred stock and shows 99,100 remaining option shares subject to the employee stock option.
Positive
- None.
Negative
- None.
Insights
Officer exercised and sold option shares, reducing direct Class A holdings materially.
The report shows an executive exercised 30,000 option shares at $40.46 and sold the same number of Class A shares on 10/07/2025, leaving 12,726 Class A shares directly held. Such combined exercise-and-sale is a common liquidity action by insiders using vested option tranches.
Key dependencies include the reported vesting schedule and remaining option pool; 99,100 option shares remain subject to vesting dates through 02/17/2026. Monitor future Form 4s for additional scheduled vesting or sales tied to those dates.
Major option exercise at low strike relative to sale prices generated significant proceeds.
The employee stock option exercise price of $40.46 contrasts with sale prices in the $355–$359 range, indicating the insider realized the spread between strike and market prices by exercising and immediately selling 30,000 shares. The filing discloses weighted-average sale prices and offers to provide breakdowns on request.
Risks and concrete items to watch include the remaining 99,100 optioned shares and their vesting schedule (noted vesting on 02/17/2025 and 02/17/2026), which could lead to additional exercises or sales within the next 12–18 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to buy) | 30,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 30,000 | $40.46 | $1.21M |
| Sale | Class A Common Stock | 6,198 | $356.051 | $2.21M |
| Sale | Class A Common Stock | 10,326 | $357.139 | $3.69M |
| Sale | Class A Common Stock | 11,680 | $358.045 | $4.18M |
| Sale | Class A Common Stock | 1,796 | $358.82 | $644K |
| holding | Series A Perpetual Strife Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stretch Preferred Stock | -- | -- | -- |
| holding | Series A Perpetual Stride Preferred Stock | -- | -- | -- |
Footnotes (1)
- The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.48 to $356.47, inclusive. The reporting person undertakes to provide to Strategy Inc ("Strategy"), any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.63 to $357.625, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.64 to $358.60, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.68 to $359.20, inclusive. The reporting person undertakes to provide to Strategy, any security holder of Strategy, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote. Of the 30,000 shares exercised on October 7, 2025 pursuant to this option, 29,100 shares vested on February 17, 2024 and 900 shares vested on February 17, 2025. Of the remaining 99,100 shares subject to this option, 49,100 shares vested on February 17, 2025 and 50,000 shares are scheduled to vest on February 17, 2026.
